Shiv Chitturi; Vincent Wai‐Sun Wong; Wah‐Kheong Chan; Grace Lai‐Hung Wong; Simon Kin‐Hung Wong; Jose Decena Sollano; Yen‐Hsuan Ni; Chun‐Jen Liu; Yu‐Cheng Lin; Laurentius Adrianto Lesmana; Seung Up Kim; Etsuko Hashimoto; Masahide Hamaguchi; Khean‐Lee Goh; Jian‐Gao Fan; Ajay Kumar. Duseja; Yock Young Dan; Yogesh Kumar Chawla; Geoff C. Farrell; Henry Lik‐Yuen Chan

Mechanistic Insights into the Pharmacological Significance of Silymarin

Molecules 27(16) (2022)

Karan Wadhwa; Rakesh Pahwa; Manish Kumar; Shobhit Kumar; Prabodh Chander Sharma; Govind Singh; Ravinder Verma; Vineet Mittal; Inderbir Singh; Deepak Kumar Kaushik; Philippe Jeandet

Effects of Dapagliflozin on Body Composition and Liver Tests in Patients with Nonalcoholic Steatohepatitis Associated with Type 2 Diabetes Mellitus: A Prospective, Open-label, Uncontrolled Study

Current Therapeutic Research 87 (2017)

Hiroshi Tobita; Shuichi Sato; Tatsuya Miyake; Shunji Ishihara; Yoshikazu Kinoshita

Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease

Liver International 34(7) (2013)

Krzysztof Kurek; Dominika Ziembicka; Patrycja Wiesiołek‐Kurek; Bartłomiej Łukaszuk; Adrian Chabowski; J Górski; Małgorzata Żendzian‐Piotrowska

Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-κB Pathway

Digestive Diseases and Sciences 63(12) (2018)

Qiang Ou; Yuanyuan Weng; Siwei Wang; Ya-Juan Zhao; Feng Zhang; Jianhua Zhou; Xiaolin Wu

Omega-3 polyunsaturated fatty acid supplementation and non-alcoholic fatty liver disease

Medicine 97(37) (2018)

Jianhui Yan; Bingjie Guan; Haiyan Gao; Xian‐E Peng

Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative review

Annals of Medicine 54(1) (2022)

Alessio Aghemo; Olga P. Alekseeva; Francesco Angelico; Игорь Геннадьевич Бакулин; Н. В. Бакулина; Dmitry S. Bordin; Alexey O. Bueverov; Oxana M. Drapkina; Anton Gillessen; Elvira M. Kagarmanova; Natalia V. Korochanskaya; U. A. Kucheryavii; Leonid Borisovich Lazebnik; Maria A. Livzan; Igor Veniaminovich Maev; Anatolii I. Martynov; М. Ф. Осипенко; Evgenii I. Sas; Antonina Vladimirovna Starodubova; Yurii P. Uspensky; E. V. Vinnitskaya; É. P. Yakovenko; Alexey A. Yakovlev

The therapeutic effect of silymarin in the treatment of nonalcoholic fatty disease

Medicine 96(49) (2017)

Sheng Zhong; Yuxiang Fan; Qi Yan; Xingyu Fan; Bo Wu; Yujuan Han; Ying Zhang; Yong Chen; Huimao Zhang; Junqi Niu

Effect of silymarin on biochemical indicators in patients with liver disease: Systematic review with meta-analysis

World Journal of Gastroenterology 23(27) (2017)

Camila Ribeiro de Avelar; Emile Miranda Pereira; Priscila Ribas de Farias Costa; Rosângela Passos de Jesús; Lucivalda Pereira Magalhães de Oliveira

Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD)

Cochrane Database of Systematic Reviews 2017(4) (2017)

Rosa Lombardi; Simona Onali; Douglas Thorburn; Brian Ritchie Davidson; Kurinchi Selvan Gurusamy; Emmanuel A. Tsochatzis

Response to pioglitazone in non-alcoholic fatty liver disease patients with vs. without type 2 diabetes: A meta-analysis of randomized controlled trials

Frontiers in Endocrinology 14 (2023)

Zeyu Wang; Du Huiqing; Ying Zhao; Yadi Ren; Cuihua Ma; Hongyu Chen; Man Li; Jiageng Tian; Caihong Xue; Guangfeng Long; Mei‐Dong Xu; Yong Jiang

The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative review

European Journal of Clinical Pharmacology 80(1) (2023)

Maria Zachou; Pagona Flevari; Narjes Nasiri Ansari; Constantinos Varytimiadis; Evangelos Kalaitzakis; Eva N. Kassi; Θεόδωρος Ανδρουτσάκος

Expert Opinion on the Management of Non-Alcoholic Fatty Liver Disease (NAFLD) in the Middle East with a Focus on the Use of Silymarin

Gastroenterology Insights 12(2) (2021)

Ahmed Hashem; Yogesh Shastri; Malfi Al Otaibi; Elwin Buchel; Hussam Saleh; Reyaz Ahmad; Hamouda Ahmed; Fateh Al Idris; Saleh Ahmed; Mohamed F. Guda; Anton Gillessen

Nuclear Receptors as Therapeutic Targets in Liver Disease: Are We There Yet?

The Annual Review of Pharmacology and Toxicology 56(1) (2016)

Swetha Rudraiah; Xi Zhang; Li Wang

Lower glycemic indices and lipid profile among type 2 diabetes mellitus patients who received novel dose of Silybum marianum (L.) Gaertn. (silymarin) extract supplement: A Triple-blinded randomized controlled clinical trial

Phytomedicine 44 (2018)

Soraiya Ebrahimpour‐Koujan; Bahram Pourghassem Gargari; Majid Mobasseri; Hadi Valizadeh; Mohammad Asghari Jafarabadi

The potential of silymarin for the treatment of hepatic disorders

Clinical Phytoscience 2(1) (2016)

Claus Hellerbrand; Jörn Markus Schattenberg; Philipp Peterburs; Anja Lechner; Reto Brignoli

Future therapy for non‐alcoholic fatty liver disease

Liver International 38(S1) (2018)

Danny Issa; Vaishali A. Patel; Arun Jayant Sanyal

Effects of silymarin on metabolic syndrome: a review

Journal of the Science of Food and Agriculture 98(13) (2018)

Maryam Vahabzadeh; Nafise Amiri; Gholamreza Karimi

Antidiabetic Drugs in NAFLD: The Accomplishment of Two Goals at Once?

Pharmaceuticals 11(4) (2018)

Matteo Tacelli; Ciro Celsa; Bianca Magro; Aurora Giannetti; Grazia Pennisi; Federica Spatola; Salvatore Petta

Metformin in the treatment of non-alcoholic fatty liver disease: safety, efficacy and mechanism

Expert Review of Gastroenterology & Hepatology 8(4) (2014)

Samir Rouabhia; Nataša Milić; Ludovico Abenavoli

Hepatoprotective effect of silymarin on fructose induced nonalcoholic fatty liver disease in male albino wistar rats

BMC Complementary Medicine and Therapies 21(1) (2021)

Tewodros Mengesha; Natesan Gnanasekaran; Tsegaye Mehare

Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD

Diseases 6(3) (2018)

Brandon J. Perumpail; Andrew A. Li; Umair Iqbal; Sandy Sallam; Neha D. Shah; Waiyee Kwong; George T. Cholankeril; Donghee Kim; Aijaz Ahmed

Protective Effects of Silymarin Against D-Gal/LPS-Induced Organ Damage and Inflammation in Mice

Drug Design Development and Therapy Volume 15 (2021)

Xin Zhao; Haoxiang Wang; Yue Yang; Yuting Gou; Zhiying Wang; Dingyi Yang; Chong V. Li

Beneficial effects of silibinin against the progression of metabolic syndrome, increased oxidative stress, and liver steatosis in P sammomys obesus, a relevant animal model of human obesity and diabetes (在一种与人类肥胖以及糖尿病相关的动物模型肥沙鼠中，水飞蓟素具有拮抗代谢综合征进展、拮抗氧化应激增加以及拮抗肝脏脂肪变性的有益作用)

Journal of Diabetes 6(2) (2013)

Saida Bouderba; Carlos Sànchez‐Martìn; Gloria R. Villanueva; Dominique Détaille; Elhadj-Ahmed Koceir

Comparison of fenofibrate and pioglitazone effects on patients with nonalcoholic fatty liver disease

European Journal of Gastroenterology & Hepatology 29(12) (2017)

Malek Yaghoubi; Sattar Jafari; Behnam Sajedi; Sepehr Gohari; Samira Akbarieh; Amir Hossein Heydari; Maryam Jameshorani

Non-alcoholic fatty liver disease: need for a balanced nutritional source

British Journal Of Nutrition 112(11) (2014)

Jayagopalan Veena; Muragundla Anjaneyulu; Srinivas Sidgiddi; Swaminathan Subramaniam

Gut microbiota modulation as a promising therapy with metformin in rats with non-alcoholic steatohepatitis: Role of LPS/TLR4 and autophagy pathways

European Journal of Pharmacology 887 (2020)

Lamiaa A. Ahmed; Maha Badr Salem; Sayed H. Seif el-Din; Naglaa Mohamed El-Lakkany; Hend Okasha; Sami Mohamed Nasr; Olfat Ali Hammam; Sanaa S. Botros; Samira Saleh

Metformin and Probiotics Interplay in Amelioration of Ethanol‐Induced Oxidative Stress and Inflammatory Response in an In Vitro and In Vivo Model of Hepatic Injury

Mediators of Inflammation 2021(1) (2021)

Farhin Patel; Kirti Parwani; Dhara N. Patel; Palash Mandal

Efficacy of Various Hypoglycemic Agents in the Treatment of Patients With Nonalcoholic Liver Disease With or Without Diabetes： A Network Meta-Analysis

Frontiers in Endocrinology 12 (2021)

Jingxuan Lian; Jianfang Fu

Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases

Clinical and Molecular Hepatology 28(3) (2022)

Han Ah Lee; Young Woon Chang; Pil Soo Sung; Eileen Laureal Yoon; Hye Won Lee; Jeong‐Ju Yoo; Young‐Sun Lee; Jihyun An; Do Seon Song; Young Youn Cho; Seung Up Kim; Yoon Jun Kim

Impact of Silymarin Supplements on Liver Enzyme Levels: A Systematic Review

Cureus 15(10) (2023)

Ernesto Calderón Martinez; Domenica Alejandra Herrera; Saruveish Mogan; Zainab Abdulrazzaq Hameed; Ayesha Altaf Jangda; Tayyaba J Khan; Palvi Mroke; Samar Sajid; Yash R. Shah; Imran Baig

State of the art

Current Opinion in Gastroenterology 30(3) (2014)

Michelle Y. Pearlman; Rohit Seth Loomba

Sirt1 and Sirt6 Mediate Beneficial Effects of Rosiglitazone on Hepatic Lipid Accumulation

PLoS ONE 9(8) (2014)

Soo Jin Yang; Jung Mook Choi; Eugene Chang; Sung Woo Park; Cheol-Young Park

Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis

Cochrane Database of Systematic Reviews 2021(7) (2021)

Oluyemi Komolafe; Elena Buzzetti; Audrey Helen Linden; Lawrence MJ Best; Angela Mary Madden; Danielle Amanda Roberts; Thomas J. G. Chase; Dominic Fritche; Suzanne C Freeman; Nicola J. Cooper; Alex J. Sutton; E‐J Milne; Kathy Wright; Chavdar S Pavlov; Brian Ritchie Davidson; Emmanuel A. Tsochatzis; Kurinchi Selvan Gurusamy

A randomized controlled clinical trial comparing calcitriol versus cholecalciferol supplementation to reduce insulin resistance in patients with non-alcoholic fatty liver disease

Clinical Nutrition 40(5) (2020)

Laleh Mahmoudi; Sara Asadi; Zahra Al-Mousavi; Ramin Niknam

Effects of Silybum marianum, Pueraria lobate, combined with Salvia miltiorrhiza tablets on non-alcoholic fatty liver disease in adults: A triple-blind, randomized, placebo-controlled clinical trial

Clinical Nutrition ESPEN 63 (2024)

Bang-yan Li; Yue Xi; Yuping Liu; Di Wang; Cheng Wang; Chaogang Chen; Xiao-hong Fang; Zhong-xia Li; Yu‐Ming Chen

Silymarin for Treating Toxic Liver Disease: International Consensus Recommendations

Gastro Hep Advances 1(5) (2022)

Anton Gillessen; Francesco Angelico; Jun Chen; Lungen Lu; M. Isabel Lucena; Qingchun Fu; Qing Xie; Raúl J. Andrade; Wen Xie; Xiaoyuan Xu; Yanyan Yu; Yimin Mao; Yuemin Nan

Hepatocellular Interactions of Potential Nutraceuticals in the Management of Inflammatory NAFLD

Cell Biochemistry and Function 42(7) (2024)

Devaraj Ezhilarasan; Langeswaran Kulanthaivel

Effects of silymarin use on liver enzymes and metabolic factors in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis

Canadian Liver Journal 7(1) (2024)

Adnan Malik; Muhammad Malik; Shahbaz Qureshi

Effect and Safety of Pioglitazone-Metformin Tablets in the Treatment of Newly Diagnosed Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease in Shaanxi Province: A Randomized, Double-Blinded, Double-Simulated Multicenter Study

Journal of Diabetes Research 2023 (2023)

Jianfang Fu; Xiao Wanxia; Xiling Gao; Jing Xu; Yang Wenjuan; Liu Jianrong; Qingzhen He; Kaiyan Ma; Jingxuan Lian; Chen Taixiong; Qian Xu; Mengying Li; Ming Jie; Qiuhe Ji

Natural Products for the Treatment of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review

Scientia Pharmaceutica 91(4) (2023)

Saverio Nucera; Rosa Maria Bulotta; Stefano Ruga; Rosamaria Caminiti; María del Rosario Serra; Roberto Bava; Fabio Castagna; Carmine Lupia; Mariangela Marrelli; Filomena Conforti; Giancarlo Antonio Statti; Vincenzo Mollace; Ernesto Palma

Evidence-based herbal treatments in liver diseases

Hepatology forum/Hepatology forum (Online) 5(1) (2024)

Methiye MANCAK KARAKUŞ; Dudu Altintas; Yasemin Balaban; Ufuk Koca Caliskan

Optimized strategy among diet, exercise, and pharmacological interventions for nonalcoholic fatty liver disease: A network meta‐analysis of randomized controlled trials

Obesity Reviews 25(6) (2024)

Hao Wang; Qianqian Ma; Youpeng Chen; Ling Luo; Junzhao Ye; Bihui Zhong

Effects of different natural products in patients with non‐alcoholic fatty liver disease—A network meta‐analysis of randomized controlled trials

Phytotherapy Research 38(7) (2024)

Hongshuai Liu; Yufei Li; Jin Yan; Xin Li; Dongxian Wang; Xiaowen Yu; Zhenyuan Jiang; Guoliang Yin; Suwen Chen; Xin Zhang; Decheng Meng; Wenfei Yu; Wenyin Jiang; Fengxia Zhang

Are alterations needed in Silybum marianum (Silymarin) administration practices? A novel outlook and meta-analysis on randomized trials targeting liver injury

BMC Complementary Medicine and Therapies 25(1) (2025)

Kasra Shahsavari; Shireen Shams Ardekani; Mohammad Reza Shams Ardekani; Majid Mokaber‐Esfahani; Hossein Kazemizadeh; Tannaz Jamialahmadi; Mehrdad Iranshahi; Mahnaz Khanavi; Maede Hasanpour

Efficacy of Hypoglycemic Agents in Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD): A Systematic Review and Network Meta‐Analysis

Journal of Evidence-Based Medicine 18(2) (2025)

Qiao Ren; Yao Tan; Guixiang Zhang; Yuzhao Dai; Lidan Yang; Yunmo Wu; He He; Jie Chen

Benefits of Combining Sonchus brachyotus DC. Extracts and Synbiotics in Alleviating Non-Alcoholic Fatty Liver Disease

Foods 12(18) (2023)

Wen-wu Huang; Boyuan Shen; Xiumei Li; Tongcun Zhang; Xiang Qin Zhou

Effects of silymarin on insulin resistance and sensitivity: A systematic review and meta-analysis of randomized controlled trials

Diabetes Research and Clinical Practice 220 (2025)

Shao Yin; Fengya Zhu; Ying Liu; Qiu Chen

Temporal Relationship between Diet-Induced Steatosis and Onset of Insulin/Leptin Resistance in Male Wistar Rats

PLoS ONE 10(2) (2015)

Li Zhang; Haiyan Song; Ying-li GE; Guang Ji; Zemin Yao

Pharmacological interventions for non-alcoholic fatty liver disease: a systematic review and network meta-analysis

Postgraduate Medical Journal 94(1116) (2018)

Kannan Sridharan; Gowri Sivaramakrishnan; Reginald Paul Sequeira; Abdelaziz Elamin

Silymarin suppresses HepG2 hepatocarcinoma cell progression through downregulation of Slit-2/Robo-1 pathway

Pharmacological Reports 72(1) (2020)

Ezgi Bektur; Sedat Kaçar; Şerife Karakaya; Varol Şahıntürk

Silymarin for Liver Disease

Elsevier eBooks (2017)

Ludovico Abenavoli; Nataša Milić

Silybin Modulates Collagen Turnover in an In Vitro Model of NASH

Molecules 24(7) (2019)

Beatrice Anfuso; Pablo José Giraudi; Claudio Tiribelli; Natalia Rosso

Silymarin Modulates Microbiota in the Gut to Improve the Health of Sow from Late Gestation to Lactation

Animals 12(17) (2022)

Shengyu Xu; Xiaojun Jiang; Xinlin Jia; Xuemei Jiang; Lianqiang Che; Yan Lin; Yong Zhuo; Bin Feng; Zhengfeng Fang; Jian Li; Jianping Wang; Zhihua Ren; De Wu

Isolation and purification of diastereoisomeric flavonolignans from silymarin by binary‐column recycling preparative high‐performance liquid chromatography

Journal of Separation Science 37(17) (2014)

Weiquan Zhao; Guang Yang; Fanyi Zhong; Nan Yang; Xin Zhao; Yunpeng Qi; Guorong Fan

Current Pharmacologic Therapy for Nonalcoholic Fatty Liver Disease

Clinics in Liver Disease 20(2) (2016)

Swaytha Ganesh; Vinod K. Rustgi

Sodium-glucose cotransporter protein-2 inhibitors and glucagon-like peptide-1 receptor agonists versus thiazolidinediones for non-alcoholic fatty liver disease: A network meta-analysis

Acta Diabetologica 59(4) (2022)

Chen Ding; Yaxin Tang; Wenqiang Zhu; Piaopiao Huang; Pingan Lian; Juanli Ran; Xiansheng Huang

The Effects of Realsil (Silybin–Phospholipid–Vitamin E Complex) on Liver Enzymes in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steato-Hepatitis (NASH): a Systematic Review and Meta-Analysis of RCTS

Acta Endocrinologica (Bucharest) 16(2) (2020)

Seyedeh‐Masomeh Derakhshandeh‐Rishehri

Comparison of efficacy of anti-diabetics on non-diabetic NAFLD: A network meta-analysis

Frontiers in Pharmacology 13 (2023)

Dachuan Jin; Zhongfeng Cui; Shunqin Jin; Tao Zhou; Baoqiang Guo; Peng Gao; Guangming Li

Comparative efficacy of diabetes medications on liver enzymes and fat fraction in patients with nonalcoholic fatty liver disease: A network meta-analysis,,

Clinics and Research in Hepatology and Gastroenterology 47(1) (2022)

Caiyan Zou; Yan Sun; Jun Liang

Effect of Medicinal Plants and Natural Products on Liver Enzymes in Non-alcoholic Fatty Liver Patients in Iran: A Systematic Review and Meta-Analysis

International Journal of Preventive Medicine 13(1) (2022)

Moloud Fakhri; Hafez Tirgar Fakheri; Mohammad Azadbakht; Mahmood Moosazadeh; Seyde Sedighe Yousefi

Effects of silymarin supplementation in late pregnancy and lactation on reproductive performance, colostrum quality, blood biochemistry and inflammation levels of sows

Tropical Animal Health and Production 57(2) (2025)

Guanglei Cong; Shuangshuang Xia; Chunxue Liu; Junbo Li; Ifen Hung; Lili Zhang; Shuaipeng Guo; Bo Zhao

Lactobacillus rhamnosus GG Combined with Metformin Alleviates Alcohol-Induced Liver Inflammation in Mice by Maintaining the Intestinal Barrier and Regulating Treg/Th1 Cells

Journal of Medicinal Food 28(4) (2025)

Yin Zhu; Yizhi Pan; Xiaozhi Wang; Li Wei; Lujian Zhu; Guo Yu; Haoran Jin; Yingying Gu; Yaqin Wang; Yongping Chen; Lanman Xu

Silymarin for adults with metabolic dysfunction-associated steatotic liver disease

Cochrane Database of Systematic Reviews 2025(6) (2025)

Caie Wang; Yiyang Shang; Ghid Kanaan; Lu Chai; Hui Li; Xingshun Qi

Effects of a low-fat diet on the hepatic expression of adiponectin and its receptors in rats with NAFLD

Annals of Hepatology 14(1) (2015)

Hong Ma; Guo-Ping You; Fan Cui; Lu-Fang Chen; Xiang-Jiu Yang; Ligang Chen; Huadong Lu; Wenqiang Zhang

The Evaluation of Effective Drugs for the Treatment of Non-Alcoholic Fatty Liver Disease: A Aystematic Review and Network Meta-Analysis

Advanced Pharmaceutical Bulletin 10(4) (2020)

Ramin Jalili; Mohammad Hossein Somi; Hossein Hosseinifard; Fatemeh Salehnia; Morteza Ghojazadeh; Nima Makhdami; Masoud Shirmohammadi

Silybin induces endothelium-dependent vasodilation via TRPV4 channels in mouse mesenteric arteries

Hypertension Research 45(12) (2022)

Xin Wen; Yidi Peng; Bohao Zheng; Shaying Yang; Jing Dong J Han; Fan Yu; Tingting Zhou; Li Geng; Zhiming Yu; Lei Feng

Sylimarin Versus Essential Phospholipids in Metabolic Associated Steatotic Liver Disease (MASLD) – A Prospective Comparative Randomized Trial

MAEDICA – a Journal of Clinical Medicine 1(1) (2024)

Teodora Ecaterina Manuc; Carmen Monica Preda; Doina Istrătescu; Liana Gheorghe; Răzvan Cerban; Carmen Cristina Ester; Tudor Gheorghe Stroie; Raluca Ioana Alecu; Claudiu Mihai Ciuciureanu; Alexandra Ioana Marin; Letiţia Tugui; Cristian George Ţieranu; Sorin Lucian ANDREI; Mircea Diculescu; Mircea Mănuc

Comparative Efficacy of Herbal Products on Metabolic Parameters in Metabolic Dysfunction–Associated Liver Disease: A Systematic Review and Network Meta-Analysis

Gastro Hep Advances 5(10) (2026)

Revathi Thirumushi Sairaj; Anna Liang; Yeison Cruz Castillo; Mariela D. Fermin Madera; Jose Medina; Tatiana Alexandra Moreno Díaz; Gabriela Flores Monar; Supritha Chintamaneni; Camila Sánchez Cruz; Rashmi Advani; Sushovan Guha; Ernesto Calderón Martinez

Iron Status and Metabolic Syndrome in Patients with Non-Alcoholic Fatty Liver Disease

Middle East Journal of Digestive Diseases 8(1) (2015)

Mohammad Ebrahim Ghamarchehreh; Nematollah Jonaidi Jafari; Mohammad Bigdeli; Hossein Khedmat; Amin Saburi

An update on nonalcoholic fatty liver disease

JAAPA 27(7) (2014)

Daniel M. Provencher

Effectiveness of drug interventions in nonalcoholic fatty liver disease: A network meta-analysis

World Journal of Diabetes 12(9) (2021)

Yizhou Huang; Gangyi Yang; Cong Wang; Xingyu Chen; Lili Zhang

Comparison of the efficacy of pioglitazone and metformin on ultrasound grade and liver enzymes level in patients with non-alcoholic fatty liver disease: A randomized controlled clinical trial

Drug Research 73(04) (2023)

Manouchehr Khoshbaten; Samineh Beheshtirouy; Shahrzad Shayanrad; Afshin Gharekhani; Haleh Rezaee

Clinical efficacy of Silybum marianum seed extract in treatment of type 2 diabetes mellitus and non-alcoholic fatty liver disease: a narrative review

Journal of Medicinal Plants 1(73) (2020)

Seyed Mohammad Mohammadi; Saeed Kianbakht; Shamsali Rezazadeh; Mojtaba Ziaee; Hasan Fallah Huseini

Neuroprotective Effect of Silymarin by Modulation of Endogenous Biomarkers in Streptozotocin Induced Painful Diabetic Neuropathy

British Journal of Pharmacology and Toxicology 4(3) (2013)

Maher M. Al-Enazi

Hepatic Biomarkers in Diabetes as Modulated by Dietary Phytochemicals

Biomarkers in disease (2017)

Arpita Basu; Paramita Basu; Timothy J. Lyons

Non Alkolik Yağlı Karaciğer Hastalığında Güncel Medikal Tedavi

Kocatepe Tıp Dergisi 16(1) (2015)

Akif Acay

Non-Alcoholic Fatty Liver Disease (NAFLD): The Search for a Cure

European Medical Journal (2016)

Abdulla Alabagi; Charity A. Reynolds; Hassan H. A‐Kader

Efficacy of Oral Supplementation with Silymarin and S-Adenosyl-L-Methioninein Patients with Non Alcoholic Fatty Liver Disease - A Pilot Study

Alternative & Integrative Medicine 05(04) (2016)

Ilaria Giangrandi; Monica Dinu; Giuditta Pagliai; Francesco Sofi; Alessandro Casini

Should We Rely on the Findings of Each Published Randomized Controlled Study?

Hepatitis Monthly 13(3) (2013)

Ali Kabir

Hepatic Biomarkers in Diabetes as Modulated by Dietary Phytochemicals

Exposure and Health (2016)

Arpita Basu; Paramita Basu; Timothy J. Lyons

Therapeutic Roles of Silymarin or/and Taurine on Nonalcoholic Fatty Liver Disease Associated with Metabolic Syndrome in Rats

Journal of Scientific Research in Science /Journal of Scientific Research in Science 32(1) (2015)

Mohamed Elsayed Zahran; Ibrahim Shahin; Kelada, A; Mohamed Heibashy

Effect of (+) and (-) hydroxycitric acid sterio-isomers present in natural products in counteracting insulin resistance

Egyptian Journal of Chemistry 0(0) (2020)

Hadir Farouk; Muhammed A. Saad; Sawsan S. Mahmoud; Mohammed F. El-Yamany; Ola A. Sharaf; Rania F. Ahmed; Ezz El-Din S. Eldenshary

Erfolgreiche Differenzialtherapie in der komplementären Praxis bei Autoimmunität

Erfahrungsheilkunde 63(06) (2014)

Stephan Wey

Har silibinin en plass i behandlingen av leversykdommer?

Tidsskrift for Den norske legeforening 134(4) (2014)

Gülen Arslan Lied; Odd Helge Gilja; Trygve Hausken

Examination of the scientific evidences for off-label use of medications in non-alcoholic fatty liver disease

Revista de Ciências Médicas e Biológicas 18(2) (2019)

Gabriela Correia Matos de Oliveira; Gustavo Magno Baptista; Elizabel Izidorio Lima; Alcina Maria Vinhaes Bittencourt; Luís Jesuino De Oliveira Andrade

Association of Serum Ferritin and Inflammatory Biomarkers with Insulin Resistance in Chinese Type 2 Diabetes Mellitus Patients

Journal of Biomedical Research & Environmental Sciences 1(7) (2020)

P Paudel; S Zhang; B Guo; A Pannu; Gajarishiyan Rasalingam; Ranjit Sah; B Desai; A Yin; C Gu; Y Yuan; L Chen; W Niu

Sylimarin: Traditional and New Effects

Рецепт(1) (2021)

Н. Н. Силивончик; Т.Н. Якубчик

The Effectiveness of Pentoxifylline in NAFLD: A Meta-Analysis

Philippine Journal of Internal Medicine 57(4) (2019)

John Mark K Torres; Carlos Rolando G. Cuaño; Janus P Ong

Comparative Efficacy of Herbal Products for Improving Liver Enzymes and Inflammation in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Network Meta-Analysis

Gastro Hep Advances 5(9) (2026)

Anna Liang; Yeison Cruz Castillo; Mariela D. Fermin Madera; Revathi Thirumushi Sairaj; Jose Medina; Tatiana Alexandra Moreno Díaz; Supritha Chintamaneni; Gabriela Flores Monar; Camila Sánchez Cruz; Rashmi Advani; Sushovan Guha; Ernesto Calderón Martinez